Revive Therapeutics (RVV.C) advanced the December 21 deal with Newscope Capital (PHRM.C) past a binding LOI and into a purchase agreement to acquire psilocybin intellectual property from Newscope’s subsidiary,…
Newscope Capital
One of the unfortunate downsides of living in the 21st century is the fact that most of us will have to deal with cancer in our lifetimes. The numbers…